Sudarshan Pharma Industries Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 24/04/2025 ,inter alia, to consider and approve Audited Standalone ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Sudarshan Pharma Industries Ltd has informed BSE that a Board of Directors meeting is scheduled for April 24, 2025. The board will, among other things, consider and approve the Audited Standalone and Consolidated Financial Results for the quarter and financial year ended March 31, 2025. The letter is signed by the Chairman & Managing Director. This is a routine intimation ahead of the full-year and Q4 FY25 results announcement.
No immediate impact on shareholders — this is a standard advance notice. Investors should watch for the actual financial results to be announced after the board meeting, which will provide clarity on the company's FY25 performance.